(Q40753373)

23 September 2017

title

Variable absorption of carbidopa affects both peripheral and central levodopa metabolism (English)

1 reference

(S)-(−)-carbidopa monohydrate

23 September 2017

1 reference

1 reference

Durso R

1

1 reference

23 September 2017

Evans JE

2

1 reference

23 September 2017

Josephs E

3

1 reference

23 September 2017

Szabo G

4

1 reference

23 September 2017

Evans B

5

1 reference

23 September 2017

Fernandez HH

6

1 reference

23 September 2017

Browne TR

7

1 reference

23 September 2017

publication date

1 August 2000

1 reference

The Journal of Clinical Pharmacology

23 September 2017

published in

1 reference

23 September 2017

volume

40

1 reference

23 September 2017

issue

8

1 reference

23 September 2017

page(s)

854-860

1 reference

Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug-induced chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Homovanillic acid measurement in clinical research: a review of methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Peripheral Pharmacokinetic Handling and Metabolism of L-Dopa in the Rat: The Effect of Route of Administration and Carbidopa Pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

High-performance liquid chromatographic method for measuring homovanillic acid in cerebrospinal fluid using electrochemical detection with internal standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Determination of acidic catecholamine metabolites in plasma and cerebrospinal fluid using gas chromatography-negative-ion mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Magnitude of response to levodopa in Parkinson disease as it relates to peripheral and central measurements of levodopa and associated metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Aromatic l-amino acid decarboxylase activity in central and peripheral tissues and serum of rats with l-dopa and l-5-hydroxytryptophan as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Further studies on catechol uptake and metabolism in rat small bowel in vivo: (1) a quantitatively significant process with distinctive structural specifications; and (2) the formation of a dopamine glucuronide reservoir after chronic L-dopa feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Pharmacokinetics of Levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Effects of peripheral aromatic l-amino acids decarboxylase inhibitor on L-[2-14C]-3,4-dihydroxy-phenylalanine metabolism in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

L-dopa decarboxylation in chronically treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Tolcapone improves motor function in parkinsonian patients with the "wearing-off" phenomenon: a double-blind, placebo-controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009585

10.1177/00912700022009585

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference